Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
T-cell responses to distinct AQP4 peptides in patients with neuromyelitis optica (NMO).
Tumour suppressor death-associated protein kinase targets cytoplasmic HIF-1α for Th17 suppression.
The Advances in Neurobiology.
Immunization of mice with a peptide derived from the HTLV-1 TAX1BP1 protein induces cross-reactive antibodies against aquaporin 4.
Novel p75 neurotrophin receptor ligand stabilizes neuronal calcium, preserves mitochondrial movement and protects against HIV associated neuropathogenesis.
Pregnancy Data in a Turkish Multiple Sclerosis Population.
Determinants of Psychosocial Difficulties Experienced by Persons with Brain Disorders: Towards a 'Horizontal Epidemiology' Approach.
How Fatigue Influences Exercise Participation in Men With Multiple Sclerosis.
Infectious and noninfectious granulomatosis in patient with multiple sclerosis: diagnostic dilemmas and followup.
Re: S Shahrbanian, M Auais, P Duquette, K Anderson, NE Mayo. Does pain in individuals with multiple sclerosis affect employment? A systematic review and meta-analysis. Pain Res Manag 2013;18(5):e94-e100.
Albumin and multiple sclerosis.
Regulator of G-protein Signaling (RGS)1 and RGS10 Proteins as Potential Drug Targets for Neuroinflammatory and Neurodegenerative Diseases.
Developmental regulation of insulin receptor gene in sciatic nerves and role of insulin on glycoprotein P0 in the Schwann cells.
Survey of Neurologist's Current Practices in Evaluation of Multiple Sclerosis to Identify Domains for a New Clinician-Reported Measure.
Relationship Between Regional Atherosclerosis and Adjacent Spinal Cord Histology.
[Molecular genetic characteristics of the virus isolated from patients with human acute encephalomyelitis and multiple sclerosis].
Neuromyelitis optica phenotype associated with therapy-responsive acute peripheral neuropathy.
Natalizumab-induced POU2AF1/Spi-B upregulation: A possible route for PML development.
Chronic inflammatory demyelinating polyneuropathy associated with alopecia totalis and Sjögren syndrome.
Increased Concentrations of Interleukin-33 in the Serum and Cerebrospinal Fluid of Patients with Multiple Sclerosis.
Quality improvement in neurology: Multiple sclerosis quality measures: Executive summary.
A Novel Asp121Asn Mutation of Myelin Protein Zero Is Associated with Late-Onset Axonal Charcot-Marie-Tooth Disease, Hearing Loss and Pupil Abnormalities.
Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
Impact of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod: Subgroup analyses of the Fingolimod Research Evaluating Effects of Daily Oral Therapy in Multiple Sclerosis (FREEDOMS) study.
Unilateral internuclear ophthalmoplegia after minor head injury.
Pages
« first
‹ previous
…
714
715
716
717
718
719
720
721
722
…
next ›
last »